Mass spectrometry techniques for determining the status of sepsis in an individual

Patent Citations (126)

Non-Patent Literature (96)

• Anthony et al., 2000, “Rapid diagnosis of bacteremia by universal amplification 23S ribosomal DNA followed by hybridization to an oligonucleotide array,” J. Clin. Microbiol. 38(2): 781-88.Applicant
• Ambroise et al., 2002, “Selection bias in gene extraction on the basis of microarray gene-expression data,” Proc. Nat'l Acad. Sci. USA 99(10): 6562-66.Applicant
• Angus et al., 2001, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Crit. Care Med. 29(7): 1303-10.Applicant
• Asadullah et al., 1995, “Immunodepression Following Neurosurgical Procedures,” Critical Care Medicine 23 (12): 1976-1983.Applicant
• BD™ Cytometric Bead Array (CBA), 2004, “Human Inflammation Kit Instruction Manual,” BD Biiosciences.Applicant
• Belobordova et al., 2000, “Small molecules originating from microbes (SMOM) and their role in microbes-host relationship,” Microb. Ecol. Health and Disease; 12:12-21.Applicant
• Beutler et al., 2003, “From phenomenon to phenotype and from phenotype to gene: Forward genetics and the problem of sepsis,” J. Infect. Dis. 187 (Suppl. 2): S321-26.Applicant
• Bone et al., 1992, “Definitions for Sepsis and Organ Failure,” Critical Care Medicine 20 (6): 724-726.Applicant
• Bright et al., 2002, “Rapid typing of bacteria using matrix-assisted laser desorption ionization time-of-flight mass spectrometry and pattern recognition software,” J. Microbiol. Methods 48: 127-38.Applicant
• Brunkhorst et al., 2002, “Diagnostic approach to sepsis-state of the rat!,” Zentralblatt fur Chirurgie; 127(3): 165-173.Applicant
• Cariou et al., 2002, “The era of genomics: impact on sepsis clinical trial design,” Crit. Care Med. 30 (Suppl.): S341-48.Applicant
• Cheadle, 1993, “The Human Leukocyte Antigens and Their Relationship to Infection,” The American Journal of Surgery 165 (2A Suppl): 75S-81S.Applicant
• Chinnaiyan et al., 2001, “Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation,” Am J Pathol. 159(4):1199-209.Applicant
• Cobb et al., 2002, “Sepsis gene expression profiling: murine splenic compared with hepatic responses determined by using complementary DNA microarrays,” Crit. Care Med. 30(12):2711-2721.Applicant
• Creighton et al., 2003, “Expression of matrix metalloproteinase 9 (MMP-9/gelatinase B) in adenocarcinomas strongly correlated with expression of immune response genes,” In Silico Biol. 3(3): 301-11.Applicant
• Dalluge, 2000, “Mass spectrometry for direct determination of proteins in cells: applications in biotechnology and microbiology,” Fresenius J. Anal. Chem. 366: 701-11.Applicant
• DeBont et al., 1999, “Plasma IL-8 and IL-6 Levels can be used to Define a Group of Low Risk of Septicaemia Among Cancer Patients with Fever and Neurtopenia,” British Journal of Haematology 107: 375-380.Applicant
• Ditschkowski et al., 1999, “HLA-DR Expression and Soluble HLA-DR Levels in Septic Patients after Trauma,” Annals of Surgery 229 (2): 246-254.Applicant
• Dollner et al., 2001, “Early diagnostic markers for neonatal sepsis: Comparing C-reactive protein, interleukin -6, soluble tumour necrosis factor receptors and soluble adhesion molecules,” J Clin Epidemiol; 54(12):1251-7.Applicant
• Drobnik et al., 2003, “Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients,” J Lipid Res; 44(4):754-61.Applicant
• Feezor et al., 2003, “Molecular Characterization of the Acute Inflammatory Response to Infections with Gram-Negative versus Gram-Positive Bacteria,” Infect Immun; 71(10):5803-13.Applicant
• Fung et al., 2002, “ProteinChip® Clinical Proteomics: Computational Challenges and Solutions,” Biotechniques; Supp1:34-8, 40-1.Applicant
• Gagnon et al., 2002, “Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages,” Cell 110: 119-31.Applicant
• Gaut et al., 2001, “Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis,” Proc Natl Acad Sci U S A; 98(21):11961-6.Applicant
• Giannoudis et al., 1998, “Stimulation of Inflammatory Markers after Blunt Trauma,” British Journal of Surgery 85: 986-990.Applicant
• Groeneveld et al., 2001, “Circulating inflammatory mediators in patients with fever: predicting bloodstream infection,” Clin. Diag. Lab. Immunol. 8(6): 1189-95.Applicant
• Hagberg, 1998, “From magnetic resonance spectroscopy to classification of tumors: a review of pattern recognition methods,” NMR Biomed. 11: 148-56.Applicant
• Harbarth et al., 2001, “Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis,” Am J Respir Crit Care Med; 164(3):396-402.Applicant
• Harper, Pyrolysis and GC in Polymer Analysis (Marcel Dekker, Inc. 1985).Applicant
• Hastie et al., The Elements of Statistical Learning (Springer-Verlag 2001).Applicant
• Healy, 2002, “New and emerging therapies for sepsis,” Annuls Pharmacother. 36: 648-54.Applicant
• Joyce et al., 2001, “Gene Expression Profile of antithromtotic protein C defines new mechanisms modulating inflammation and apoptosis,” J. Biol. Chem. 276(14): 11,199-203.Applicant
• Karzai et al., 1998, “Sepsis: definitions and diagnosis,” Int'l J. Crit. Practice 95 (Suppl.): 44-48.Applicant
• Knaus et al., 1991, “The Apache III Prognostic System—Risk Prediction of Hospital Morality for Critically Ill Hospitalized Adults,” Chest 100 (6): 1619-1636.Applicant
• Kuster et al., 1998, “Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation,” Lancet 352(9136):1271-1277.Applicant
• Lam et al., 2003, “Time course of early and late changes in plasma DNA in trauma patients,” Clin. Chem. 49(8): 1286-91.Applicant
• Llewelyn et al., 2001, “Diagnosis of infection in sepsis,” Intensive Care Med. 27: S10-S32.Applicant
• Manjuck et al., 2000, “Decreased Response to Recall Antigens is Associated with Depressed Costimulatory Receptor Expression in Septic Critically Ill Patients,” Journal Laboratory Clinical Medicine 135 (2): 153-160.Applicant
• Marshall et al., 2003, “Measures, markers, and mediators: Toward a staging system for clinical sepsis. A report from the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, Oct. 25-26, 2000,” Crit. Care Med. 31(5): 1560-67.Applicant
• Members Of The American College Of Chest Physicians/Society Of Critical Care Medicine Consensus Conference Committee, 1992, “American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Crit. Care Med. 20(6): 864-74.Applicant
• Millili et al., 1998, “Predicting Surgical Outcome Using Bayesian Analysis,” Journal of Surgical Research 77: 45-49.Applicant
• Muller et al., 2000, “Calcitonin Precursors are Reliable Markers of Sepsis in a Medical Intensive Care Unit,” Critical Care Medicine 4: 977-983.Applicant
• Muret et al., 2000, “Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures”, Shock 13(3): 169-74.Applicant
• Nadel, 2002, “Helping to understand studies examining genetic susceptibility to sepsis,” Clin. Exp. Immunol. 127: 191-92.Applicant
• Natanson et al., 1998, “The sirens' songs of confirmatory sepsis trials: selection bias and sampling error,” Crit. Care Med. 26(12): 1927-31.Applicant
• Nupponen et al., 2001, “Neutrophil CD11b Expression and Circulating Interleukin-8 as Diagnostic Markers for Early-Onset Neonatal Sepsis,” Pediatrics 108 (1): 1-6.Applicant
• Oberholzer et al., 2001, “Sepsis syndromes: understanding the role of innate and acquired immunity,” Shock 16: 83-96.Applicant
• Oczenski, 2003, “HLA-DR as a Marker for Increased Risk for Systemic Inflammation and Septic Complications after Cardiac Surgery,” Intensive Care Medicine 29: 1253-1257.Applicant
• Paterson et al., 2002, “Sepsis and the systemic inflammatory response syndrome,” J.R. Col.. Surg. Edinb. 127: 191-92.Applicant
• Pathan et al., 2003, “The complexity of the inflammatory response to the meningococcal sepsis revealed by gene expression profiling using cDNA microarrays,” Crit. Care Med; 31(12 Suppl.): A47.Applicant
• Perry et al., 2003, “Is Low Monocyte HLA-DR Expression Helpful to Predict Outcome in Severe Sepsis?” Intensive Care Medicine 29: 1245-1252.Applicant
• Petricoin et al., 2002, “Use of proteomic patterns in serum to identify ovarian cancer,” Lancet 359: 572-77.Applicant
• Presto Elgstoen et al., 2001, “Potential of capillary electrophoresis, tandem mass spectrometry and coupled capillary electrophoresis-tandem mass spectrometry as diagnostic tools,” J. Chromatogr. A; 914: 265-275.Applicant
• Rangel-Frausto et al., 1995, “The natural history of the systemic inflammatory response syndrome (SIRS),” J. Am. Med. Ass'n. 273: 117-23.Applicant
• Rangel-Frautso et al., 1998, “The Dynamics of Disease Progression in Sepsis: Markov Modeling Describing the Natural History and the Likely Impast of Effective Antisepsis Agents,” Clinical Infectious Diseases 27: 185-190.Applicant
• Reinhart et al., 2002, “Markers of endothelial damage in organ dysfunction and sepsis, ”Crit. Care Med. 30(5): S302-12.Applicant
• Rixen et al., 1996, “Sepsis/SIRS', Physiologic Classification, Severity Stratification, Relation to Cytokine Elaboration and Outcome Prediction in Posttrauma Illness,” J. Trauma 41(4): 581-598.Applicant
• Roumen et al., 1993, “Scoring systems and blood lactate concentrations in relation to the development of Adult Respiratory Distress Syndrome and Multiple Organ Failure in severely traumatized patients,” J. Trauma 35(3): 349-55.Applicant
• Sambrook et al., Molecular Cloning (3rd ed., Cold Spring Harbor Laboratory Press 2001).Applicant
• Sauaia et al., 1994, “Early Predictors of Postinjury Multiple Organ Failure,” Arch. Surgery 129: 39-45.Applicant
• Selberg et al., 2000, “Discrimination of Sepsis and Systematic Inflammatory Response Syndrome by Determination of Circulating Plasma Concentrations of Procalcitonin, Protein Complement 3a, and Interleukin-6,” Crit. Care Med. 28 (i): 2793-2798.Applicant
• Shoemaker et al., 2002, “Recent developments in DNA microarrays,” Curr. Opinion Microbiol. 5: 334-37.Applicant
• Slotman et al., 2002, “Prospectively Validated Prediction of Physiologic Variables and Organ Failure in Septic Patents: The Systemic Mediator Associated Response Test (SMART),” Critical Care Medicine 30 (5): 1035-1045.Applicant
• Slotman et al., 1997, “Multivariate Regression Modeling for the Prediction of Inflammation, Systemic Pressure, and End-organ Function in Severe Sepsis,” Shock 8 (3): 225-231.Applicant
• Slotman et al., 2000, “Prospectively validated predictions of shock and organ failure in individual spetic surgical patients: the Systemic Mediator Associated Response Text,” Crit. Care 2000 4(5): 319-26.Applicant
• Smith et al., 2004, “Impact of immunomodulatory oligodeoxynucleotides on cytokine production in the lipopolysaccharide-stimulated human whole blood model,” Surgery 136(2):464-472.Applicant
• Stordeur et al., 2002, “Cytokine mRNA quantification by real-time PCR,” J. Immunol. Methods 259: 55-64.Applicant
• Suzuki et al., 2000, “Comprehensive gene expression profile of LPS-stimulated human monocytes by Sage,” Blood; 96(7):2584-91.Applicant
• Takala et al., 2002, “Markers of inflammation in sepsis,” Annuls Med. 34: 614-23.Applicant
• Takala et al., 1999, “Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency,” Clin. Sci. 96:287-95.Applicant
• Tan et al., 2002, “The gene expression fingerprint of human heart failure,” Proc. Nat'l Acad. Sci. USA 99: 11387-92.Applicant
• Taniguchi et al., 1999, “Change in the Ratio of Interleukin-6 to Interleukin-10 Predicts a Poor Outcome in Patients with Systemic Inflammatory Response Syndrome,” Critical Care Medicine 27 (7): 1262-1264.Applicant
• Tarnok et al., 2003, “Cytometric bead array to measure six cytokines in twenty-five microliters of serum,” Clin. Chem. 49(6): 1000-02.Applicant
• Titus, 2003, “Latest assay opens another sepsis frontier,” College of American Pathologists, CAP Today, at http://www.cap.org/apps/docs/cap—today/feature—stories/sepsis.html (posted May 2003).Applicant
• Van den Berk et al., 1997, “Low HLA-DR Expression on Monocytes as a Prognostic Marker for Bacterial Sepsis after Liver Transplantation,” Transplantation 63 (12): 1846-1848.Applicant
• Van Leeuwen et al., 2003, “Lipoprotein metabolism in patients with severe sepsis,” Crit. Care Med. 31(5): 1359-66.Applicant
• Venables et al., Modern Applied Statistics with S (4th ed., Springer 2002).Applicant
• Vincent et al., The Sepsis Text (Carlet et al., eds., Kluwer Academic Publishers 2002).Applicant
• von Landenberg et al., 2001, “New approaches in the diagnosis of sepsis,” Isr. Med. Assoc. J. 3: 439-42.Applicant
• Wagner et al., 1994, “Daily Prognostic Estimates for Critically Ill Adults in Intensive Care Units: Results from a Prospective, Multicenter, Inception Cohort Analysis,” Critical Care Medicine 22 (9): 1359-1372.Applicant
• Wagner et al., 2002, “Interpretation of static time-of flight secondary ion mass spectra of adsorbed protein films by multvariate pattern recognition,” Anal. Chem. 74: 1824-35.Applicant
• Wagner et al., 2002, “Interpretation of static time-of-flight secondary ion mass spectra of adsorbed protein films by multivariate pattern recognition,” Anal. Chem. 74: 1824-35.Applicant
• Wakefield et al., 1993, “Polymorphonuclear Leukocyte Activation. An Early Marker of the Postsurgical Sepsis Response,” Arch. Surg. 128: 390-395.Applicant
• Wakefield et al., 1993, “Changes in Major Histocompatibility Complex Class II Expression in Monocytes and T cells of Patients Developing Infection after Surgery,” British Journal of Surgery 80(2): 205-209.Applicant
• Wakefield et al., 1995, “Surgery and the Release of a Neutrophil Fcy Receptor,” The American Journal of Surgery 170: 277-284.Applicant
• Wang et al., 1998, “Tissue coexpression of LBP and CD14 mRNA in a mouse model of sepsis,” J. Surg. Res. 76(1):67-73.Applicant
• Wei et al., 1999, “Desorption-ionization mass spectrometry on porous silicon,” Nature 399: 243-46.Applicant
• Weigand et al., 1999, “Gene Expression Pattern in Human Monocytes as a Surrogate Marker for Systemic Inflammatory Response Syndrome (SIRS),” Mol Med; 5(3):192-202.Applicant
• Weinstein et al., 1997, “The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults,” Clin. Infectious Diseases 24: 584-602.Applicant
• Weirich et al., 1998, “Neutrophil CD11b Expression as a Diagnostic Marker for Early-Onset Neonatal Infection,” The Journal of Pediatrics 132 (ss.3,1): 445-451.Applicant
• Weglohner et al., 2001, “Isolation and characterization of serum procalcitonin from patients with sepsis,” Peptides 22: 2099-2103.Applicant
• Wert et al., 2000, “Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice,” Proc. Natl. Acad. Sci. USA 97(11):5972-5977.Applicant
• Zhang et al., 2001, “Recursvie partitioning for tumor classification with gene expression microarray data,” Proc Natl Acad Sci U S A; 98(12):6730-5.Applicant
• Zhao et al., 2001, “Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays,” Am. J. Physiol. Cell Physiol. 281(5): C1587-95 (Nov. 2001).Applicant
• Zhu et al., 1997, “Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis,” Cytokine 9(6):437-446.Applicant
• Zou, et al., 2002, “Application of cDNA microassays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon,” Oncogene 21: 4855-62.Applicant